Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC

This study has been completed.
Sponsor:
Collaborator:
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00488982
First received: June 18, 2007
Last updated: October 26, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)